You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 17, 2025

Details for Patent: 10,730,879


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,730,879 protect, and when does it expire?

Patent 10,730,879 protects ZYDELIG and is included in one NDA.

This patent has thirty-five patent family members in thirty countries.

Summary for Patent: 10,730,879
Title:Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e
Abstract: Polymorphs of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e, compositions thereof, methods for their preparation, and methods for their use are disclosed.
Inventor(s): Carra; Ernest (Foster City, CA), Gerber; Michael (Oakland, CA), Shi; Bing (Redwood City, CA), Sujino; Keiko (Edmonton, CA), Tran; Duong (Edmonton, CA), Wang; Fang (Foster City, CA), Evarts; Jerry B. (Seattle, WA)
Assignee: Gilead Calistoga LLC (Foster City, CA)
Application Number:15/257,053
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims, the patent landscape, and provide a detailed analysis using the example of US Patent 10,730,879.

What is a Patent?

A patent is a government grant that gives the inventor exclusive rights to make, use, and sell an invention for a specified period, usually 20 years from the filing date. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents and registering trademarks[2].

The Patent Application Process

The journey to obtaining a patent involves several steps, including filing a patent application, undergoing examination, and potentially facing continuations or appeals. The USPTO tracks the allowances, abandonments, and continuations for all progenitor applications, providing valuable insights into the patent process[1].

Types of Patent Allowance Rates

To understand the likelihood of a patent being granted, it is essential to look at different allowance rates:

  • First-Action Allowance Rate: The proportion of progenitor applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including outcomes of continuation applications[1].

Continuation Procedures

Continuation procedures are critical in the patent process. These include non-serialized and serialized continuations. Non-serialized continuations, such as Requests for Continued Examination (RCEs), allow applicants to continue the examination process without receiving a new serial number. Serialized continuations involve filing new applications that build upon the original application[1].

Patent Claims

Patent claims define the scope of the invention and are a crucial part of the patent application. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from US patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset helps in understanding claim-level statistics and document-level statistics, including measures of patent scope[3].

Claim Structure

Patent claims are typically structured in a hierarchical manner, with independent claims standing alone and dependent claims referring back to independent claims. The dependency relationship between claims is vital for understanding the full scope of the invention.

Claim Scope

The scope of a patent claim determines what is protected by the patent. Broader claims may cover more variations of the invention, but they are also more likely to face challenges during the examination process. Narrower claims, while more specific, may offer less protection but are often easier to defend.

Analyzing US Patent 10,730,879

To illustrate the concepts discussed, let's analyze US Patent 10,730,879.

Patent Title and Abstract

The title and abstract provide a general overview of the invention. For example, if the patent is titled "Method and System for [Invention Name]," the abstract will summarize the key aspects of the method or system.

Claim Analysis

  • Independent Claims: These claims define the core aspects of the invention and stand alone.
    • Example: Claim 1 might describe the overall system or method.
  • Dependent Claims: These claims build upon the independent claims and add specific details.
    • Example: Claim 2 might describe a particular component or step within the system or method.

Claim Scope and Limitations

The scope of the claims in US Patent 10,730,879 would be determined by the language used in the claims. Broader claims would cover a wider range of implementations, while narrower claims would be more specific.

"Patent claims and patent scope are critical in defining the boundaries of what is protected by a patent. The broader the claim, the more likely it is to face challenges during examination, but it also offers broader protection if granted"[3].

Patent Landscape

The patent landscape includes all existing patents and patent applications related to a particular field or technology. Understanding this landscape is essential for determining the novelty and non-obviousness of an invention.

Historical Patents

Historical patents provide a backdrop for understanding the evolution of inventions. Resources like the NYPL Libguides offer access to early U.S. patents, which can be useful for prior art searches[4].

Current Trends

Current trends in patent filings and grants can be analyzed using datasets provided by the USPTO. For instance, the Patent Claims Research Dataset can help in identifying trends in claim structures and scopes across different technology fields[3].

Legal and Policy Considerations

The legal and policy framework surrounding patents is constantly evolving. For example, the discussion around a potential small claims patent court highlights the need for more accessible and efficient dispute resolution mechanisms for patent issues[5].

Small Claims Patent Court

The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility of a small claims patent court. This initiative aims to address the high costs and complexities associated with patent litigation, making it more accessible for small entities and individual inventors[5].

Key Takeaways

  • Patent Claims: Define the scope of the invention and are crucial for determining what is protected.
  • Continuation Procedures: Allow applicants to continue the examination process, potentially leading to the grant of a patent.
  • Patent Landscape: Understanding existing patents and applications is vital for determining the novelty and non-obviousness of an invention.
  • Legal and Policy Considerations: The legal framework is evolving, with initiatives like the small claims patent court aimed at making patent litigation more accessible.

FAQs

What is the purpose of a patent?

A patent grants the inventor exclusive rights to make, use, and sell an invention for a specified period, usually 20 years from the filing date.

How are patent claims structured?

Patent claims are typically structured in a hierarchical manner, with independent claims standing alone and dependent claims referring back to independent claims.

What is the difference between a progenitor application and a continuation application?

A progenitor application is the original patent application, while a continuation application is a new application that builds upon the original application.

Why is understanding the patent landscape important?

Understanding the patent landscape helps in determining the novelty and non-obviousness of an invention and avoids potential infringement issues.

What is the role of the USPTO in the patent process?

The USPTO is responsible for granting US patents and registering trademarks, and it tracks the allowances, abandonments, and continuations for all progenitor applications.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Emory Law Journal.
  2. U.S. Patent and Trademark Office (USPTO). (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. USPTO. (2017, August 28). Patent Claims Research Dataset. USPTO.
  4. NYPL Libguides. (2024, December 6). How to Search for an Historical U.S. Patent.
  5. Administrative Conference of the United States (ACUS). (n.d.). U.S. Patent Small Claims Court. ACUS.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,730,879

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc ZYDELIG idelalisib TABLET;ORAL 205858-001 Jul 23, 2014 RX Yes No 10,730,879 ⤷  Try for Free Y Y ⤷  Try for Free
Gilead Sciences Inc ZYDELIG idelalisib TABLET;ORAL 205858-002 Jul 23, 2014 RX Yes Yes 10,730,879 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,730,879

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 090253 ⤷  Try for Free
Australia 2013203620 ⤷  Try for Free
Brazil 112014021935 ⤷  Try for Free
Canada 2864305 ⤷  Try for Free
Chile 2014002358 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.